EMA — authorised 28 March 2019
- Marketing authorisation holder: TEVA GMBH
- Status: approved
EMA authorised Ajovy on 28 March 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 28 March 2019.
TEVA GMBH holds the EU marketing authorisation.